George Washington University Hematology and Medical Oncology Best Practices On Demand 2025

• Include:  videos +  audios + pdfs, size:  GB
• Target Audience: hematology/oncology certification exams
• Sample video: contact me for sample video
• Information:

Course Features

All registered attendees receive:

Instruction by the nation’s leading clinician-educators

Access to Course Electronic Syllabus and Slide Handouts

All content can be conveniently accessed from your computer, mobile device, or smartphone

Target Audience

Learning Objectives

At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:

Hematology

Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors

Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies

Understand blood and marrow morphology and hematopathology

Understand red cell disorders

Hematologic Malignancies

Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs

Be familiar with the diagnosis, evaluation, and management of hematologic malignancies

Identify strategies for taking the board examinations

Oncology

Understand the epidemiology of malignant diseases and management of the medical complications of malignancy

Comprehend the principles of management of gynecologic and other genito-urinary malignancies

Identify the latest advances in cancers of the lung, the breast, and the gastrointestinal tract

Recognize principles of new developments in biologic therapy of cancer

• Topics:

2025 HEMONC Best Practices Course Syllabus FULL SESSION COURSE.pdf

Hematology Sessions:

Session 0 (Hematology): Anemias, Porpyrias, Red Cell Enzymes, Clotting, Cellular Morphology and Liquid Biopsies (4.00 hours)

Session 1: Iron Deficiency, Hemoglobinopathies, Hemolytic Anemia, Hemophilias, Transfusion Medicine, Hematologic Complications of Pregnancy and Platelet Alloimmunization (9.00 hours)

Hematologic Malignancies Sessions:

Session 3: Lymphomas, Multiple Myeloma, MGUS, ALL, CML, Plasma Cell Disorders, Myelodysplasia, Waldenstrom’s Macroglobulinemia and Palliative Care (9.25 hours)

Session 4: AML, Bone Marrow Transplantation, Myeloproliferative Neoplasms, CLL, Pharmacology and T Cell Therapies (9.25 hours)

Medical Oncology Sessions:

Session 6: Renal Cell, Prostate, Bladder, Testicular, Ovarian, Endometrial Tumors, Melanoma, Carcinoid Tumors and Mesothelioma (10.00 hours)

Session 7: GI Oncology, Pancreatic Cancer and Sarcomas (6.75 hours)